Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy

ELAC2 is a ubiquitously expressed enzyme potentially involved in tRNA processing and cell signaling pathways. Mutations of the ELAC2 gene have been found to confer increased prostate cancer susceptibility in families. ELAC2 protein expression was analyzed by immunohistochemistry in 9,262 patients an...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Schroeder, Cornelia, Navid-Hill, Elham, Meiners, Jan, Hube-Magg, Claudia, Kluth, Martina, Makrypidi-Fraune, Georgia, Simon, Ronald, Büscheck, Franziska, Luebke, Andreas M., Goebel, Cosima, Lang, Dagmar S., Weidemann, Sören, Neubauer, Emily, Hinsch, Andrea, Jacobsen, Frank, Lebok, Patrick, Michl, Uwe, Pehrke, Dirk, Huland, Hartwig, Graefen, Markus, Schlomm, Thorsten, Sauter, Guido, Höflmayer, Doris
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2019
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6697635/
https://ncbi.nlm.nih.gov/pubmed/31452838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27132
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak